Wolverine Trading, LLC Krystal Biotech, Inc. Put Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$174.7 - $213.66 $838,560 - $1.03 Million	4,800 New	4,800 $872,000
Q3 2023 Nov 15, 2023	SELL	$108.51 - $130.22 $32,553 - $39,066	-300 Reduced 10.0%	2,700 $313,000
Q2 2023 Aug 23, 2023	BUY	$78.48 - $130.32 $235,440 - $390,960	3,000 New	3,000 $352,000
Q4 2022 Feb 14, 2023	BUY	$63.14 - $79.9 $265,188 - $335,580	4,200 New	4,200 $333,000
Q3 2021 Nov 12, 2021	SELL	$52.01 - $71.77 $156,030 - $215,310	-3,000 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$62.14 - $81.82 $186,420 - $245,459	3,000 New	3,000 $207,000

310

24.3M

483K

364K

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.13B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.